Delinia's Acquisition

Delinia was acquired by Celgene on January 26, 2017.

Delinia was founded to discover and develop novel therapeutics for the treatment of autoimmune and inflammatory diseases. Delinia's lead program is a molecule that selectively potentiates and expands …

Articles about Delinia's Acquisition: